Array ( [1610085991] => Array ( [wordfence_batchReportBlockedAttempts] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => [args] => Array ( ) ) ) ) [1610086221] => Array ( [wordfence_processAttackData] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => [args] => Array ( ) ) ) ) [1610086392] => Array ( [wordfence_hourly_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1610087085] => Array ( [recovery_mode_clean_expired_keys] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610087973] => Array ( [wp_privacy_delete_old_export_files] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1610088481] => Array ( [wpm_update_stats] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => hourly [args] => Array ( ) [interval] => 3600 ) ) ) [1610089712] => Array ( [ai1wm_storage_cleanup] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610094994] => Array ( [publish_future_post] => Array ( [b9c668cdbd28081703406cf7c03cfb2e] => Array ( [schedule] => [args] => Array ( [0] => 554406 ) ) ) ) [1610095771] => Array ( [wp_scheduled_auto_draft_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610100911] => Array ( [delete_expired_transients] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610100952] => Array ( [wpseo-reindex-links] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610101614] => Array ( [wordfence_daily_cron] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610112726] => Array ( [wp_update_themes] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) [wp_update_plugins] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1610113474] => Array ( [wp_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610116153] => Array ( [wp_version_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1610119073] => Array ( [wp_session_garbage_collection] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => twicedaily [args] => Array ( ) [interval] => 43200 ) ) ) [1610122024] => Array ( [akismet_scheduled_delete] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610125011] => Array ( [yoast_tracking] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610142061] => Array ( [wpseo_permalink_structure_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) [wpseo_home_url_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610142074] => Array ( [wpseo-reindex] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => daily [args] => Array ( ) [interval] => 86400 ) ) ) [1610200200] => Array ( [wordfence_start_scheduled_scan] => Array ( [bc933a31721c9360c7121ad12a21edba] => Array ( [schedule] => [args] => Array ( [0] => 1610200200 ) ) ) ) [1610459400] => Array ( [wordfence_start_scheduled_scan] => Array ( [8a5658e03958f7d8e19261706e1338c0] => Array ( [schedule] => [args] => Array ( [0] => 1610459400 ) ) ) ) [1610519090] => Array ( [wp_site_health_scheduled_check] => Array ( [40cd750bba9870f18aada2478b24840a] => Array ( [schedule] => weekly [args] => Array ( ) [interval] => 604800 ) ) ) )
Etiquetas: Antidiabéticos orales, Aspectos generales, Atención, Atención de enfermería, Autoanálisis, Complicaciones, Consejo General de Enfermería, Control, Control glucémico, Controles, Diabético, Diagnostico precoz, Diagnósticos de enfermería, Dieta, Educación para la salud, Ejercicio, Enfermería, Epidemiología, Insulina, Intervención de enfermería, Madrid, Noviembre 2010, Paciente, Paciente diabético, Recomendaciones sanitarias, Seguimiento, Signos, Sintomas, Terapia con insulina, Tratamiento, Valoración de enfermería.
Etiquetas: 14 mayo 2007, 14/05/2007, 14/05/2008, 2005/2006, Abatacept, Agencia Europea de Medicamentos, Antibacterianos, Antidiabéticos, Antidiabéticos orales, Antitrombóticos, Autorizaciones de medicamentos, Citostáticos, Colesevelam, Darunavir, Decitabina, Deferasirox, EMEA, Entecavir, Estiripentol, Eszopiclona, Exenatida, Fanolesomab 99 Tc, FDA, Fluoroquinolonas, Food Drug Administration, Gemtuzumab ozogamicina, Grupo, Hormonas hipotalámicas e hipofisarias, Hormonas liberadores de gonadotropinas, Inmunoestimulantes, Inmunosupresores selectivos, Ivermectina, Laboratorio, Laxantes, Lenalidomida, Lubiprostona, Madrid, Medicamento, medicamentos, Micafungina, Natalizumab, Nepafenaco, Nuevos principios activos, PaM digital, Panitumumab, Panorama Actual del Medicamento, Parches de testosterona, Perflutren, Porfímero, Pramlintida, Principio activo, Rimonabant, Rufinamida, salud, Sanidad, Secretina, Sitaxentán, Telbivudina, Temoporfina, Terapia cardiaca, Ziconotida, Zileuton.